Panayotis Kaloyannidis

发表

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation

J. Connors, P. Kaloyannidis, M. Hertzberg, 2019, British journal of haematology.

Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?

P. Kaloyannidis, J. Apostolidis, Panayotis Kaloyannidis, 2021, Current Treatment Options in Oncology.

The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats.

E. Yannaki, A. Anagnostopoulos, P. Kaloyannidis, 2010, Arthritis and rheumatism.

The Role of Low‐dose Anti‐thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies

E. Yannaki, A. Anagnostopoulos, N. Stavroyianni, 2017, Clinical lymphoma, myeloma & leukemia.

The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.

D. Mallouri, P. Kaloyannidis, Panayotis Kaloyannidis, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2018, Journal of clinical apheresis.

Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2018, Clinical transplantation.

Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells.

A. Xagorari, E. Yannaki, A. Anagnostopoulos, 2006, Experimental hematology.

Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host

E. Yannaki, A. Anagnostopoulos, Andriana Lazaridou, 2019, Bone Marrow Transplantation.

Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges.

E. Yannaki, P. Kaloyannidis, A. Papadopoulou, 2016, Critical reviews in oncology/hematology.

Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemia.

E. Yannaki, A. Anagnostopoulos, M. Arsenakis, 2010, Human gene therapy.

Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

G. Stamatoyannopoulos, A. Xagorari, T. Papayannopoulou, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience.

P. Kaloyannidis, E. Eldebawy, J. Apostolidis, 2020, Clinical lymphoma, myeloma & leukemia.

Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation.

I. Georgoulis, E. Yannaki, A. Anagnostopoulos, 2006, Thrombosis research.

The Impact of Desferrioxamine Postallogeneic Hematopoietic Cell Transplantation in Relapse Incidence and Disease-Free Survival: A Retrospective Analysis

E. Yannaki, A. Anagnostopoulos, A. Athanasiadou, 2010, Transplantation.

Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2015, Leukemia & lymphoma.

Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma

P. Kaloyannidis, M. Darweesh, J. Apostolidis, 2020, Journal of immunology research.

Function of the hypothalamic–pituitary–gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases

D. Panidis, I. Sakellari, P. Kaloyannidis, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

M. Aljurf, R. Almaghrabi, M. Ayas, 2021, Bone Marrow Transplantation.

Outcomes of Hodgkin's lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation.

P. Repousis, A. Anagnostopoulos, I. Sakellari, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2015, Leukemia & lymphoma.

Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis

E. Yannaki, A. Anagnostopoulos, A. Fassas, 2012, Annals of the rheumatic diseases.

Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host

E. Yannaki, A. Anagnostopoulos, Andriana Lazaridou, 2019, Bone Marrow Transplantation.

Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.

S. Papageorgiou, V. Pappa, A. Anagnostopoulos, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.

S. Papageorgiou, A. Anagnostopoulos, I. Sakellari, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Hyperdiploidy is a Positive Prognostic Factor for Progression-Free Survival in Multiple Myeloma with High and Intermediate Risk Cytogenetics

Mahmoud M. Kamel, P. Kaloyannidis, O. Abduljalil, 2018 .

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??

P. Kaloyannidis, F. Abdulla, E. Mutahar, 2022, Journal of blood medicine.

The Impact of Desferrioxamine Postallogeneic Hematopoietic Cell Transplantation in Relapse Incidence and Disease-Free Survival: A Retrospective Analysis

E. Yannaki, A. Anagnostopoulos, A. Athanasiadou, 2010, Transplantation.

GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation

A. Barbouti, E. Yannaki, I. Sakellari, 2013, Bone Marrow Transplantation.

low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimens.

E. Yannaki, I. Sakellari, I. Batsis, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis

G. Vassilopoulos, K. Konstantopoulos, M. Angelopoulou, 2018, Hematological oncology.

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

P. Kaloyannidis, S. Kanfar, I. Apostolidis, 2018, Bone Marrow Transplantation.

Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge

M. Afrit, T. Morrison, A. R. El Kinge, 2022, Clinics and practice.

Non‐transplantable cord blood units as a source for adoptive immunotherapy of leukaemia and a paradigm of circular economy in medicine

E. Yannaki, A. Anagnostopoulos, P. Papayanni, 2021, British journal of haematology.